Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,863 | 135 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $390.18 | 30 | $0 (2024) |
| UCB, Inc. | $306.08 | 14 | $0 (2024) |
| PFIZER INC. | $219.63 | 12 | $0 (2024) |
| Lilly USA, LLC | $215.29 | 11 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $199.15 | 9 | $0 (2023) |
| Medtronic, Inc. | $187.57 | 2 | $0 (2021) |
| Amgen Inc. | $161.39 | 7 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $140.15 | 5 | $0 (2024) |
| Neurelis, Inc. | $109.88 | 4 | $0 (2023) |
| Horizon Therapeutics plc | $105.43 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $862.66 | 40 | PFIZER INC. ($157.66) |
| 2023 | $859.41 | 49 | AbbVie Inc. ($151.49) |
| 2022 | $843.74 | 40 | ABBVIE INC. ($183.38) |
| 2021 | $245.31 | 5 | Medtronic, Inc. ($187.57) |
| 2019 | $51.95 | 1 | Alexion Pharmaceuticals, Inc. ($51.95) |
All Payment Transactions
135 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $29.08 | General |
| Category: Neurology | ||||||
| 12/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: PAIN | ||||||
| 12/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: PAIN | ||||||
| 12/11/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $24.73 | General |
| Category: PSYCHIATRY | ||||||
| 11/27/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: PAIN | ||||||
| 11/19/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $29.80 | General |
| Category: Neurology | ||||||
| 11/19/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $27.46 | General |
| Category: Rare Disease | ||||||
| 11/11/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $35.11 | General |
| Category: Neurology | ||||||
| 11/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: PAIN | ||||||
| 11/05/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Neuroscience | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Neurology | ||||||
| 10/24/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Neuroscience | ||||||
| 10/18/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Neurology | ||||||
| 10/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: PAIN | ||||||
| 10/15/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 10/09/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Rare Disease | ||||||
| 09/26/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: NEUROLOGY | ||||||
| 09/24/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Neurology | ||||||
| 09/11/2024 | Octapharma USA, Inc. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Neuroscience | ||||||
| 08/13/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: Neuroscience | ||||||
| 08/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: PAIN | ||||||
| 07/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: PAIN | ||||||
| 07/25/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/10/2024 | Octapharma USA, Inc. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 418 | 694 | $221,190 | $51,029 |
| 2022 | 13 | 445 | 826 | $262,434 | $56,796 |
| 2021 | 13 | 536 | 880 | $308,768 | $68,722 |
| 2020 | 13 | 524 | 985 | $307,355 | $71,976 |
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 104 | 182 | $70,378 | $16,528 | 23.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 87 | 89 | $47,646 | $11,286 | 23.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 17 | 35 | $23,144 | $5,338 | 23.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 42 | 42 | $21,166 | $4,755 | 22.5% |
| G0453 | Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | Facility | 2023 | 20 | 164 | $16,200 | $4,096 | 25.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 40 | 51 | $11,746 | $3,136 | 26.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 19 | $6,403 | $1,675 | 26.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 15 | $5,936 | $1,101 | 18.6% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 23 | 24 | $10,374 | $1,008 | 9.7% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 19 | 22 | $3,664 | $954.82 | 26.1% |
| 95938 | Placement of skin electrodes and measurement of stimulated sites on arms and legs | Facility | 2023 | 19 | 19 | $2,621 | $666.14 | 25.4% |
| 95870 | Needle measurement of electrical activity in arm, leg, trunk or head muscles, limited study | Facility | 2023 | 16 | 32 | $1,912 | $484.48 | 25.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 90 | 92 | $54,096 | $13,521 | 25.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 87 | 140 | $54,880 | $13,398 | 24.4% |
| G0453 | Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | Facility | 2022 | 29 | 294 | $29,988 | $7,598 | 25.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 22 | 33 | $26,565 | $5,464 | 20.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 42 | 59 | $17,759 | $4,536 | 25.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $12,168 | $3,048 | 25.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 18 | 18 | $12,042 | $2,617 | 21.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 25 | 39 | $8,190 | $2,187 | 26.7% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 26 | 28 | $34,300 | $1,275 | 3.7% |
| 95938 | Placement of skin electrodes and measurement of stimulated sites on arms and legs | Facility | 2022 | 28 | 28 | $4,004 | $1,016 | 25.4% |
| 95822 | Measurement of brain wave activity (eeg), in coma or asleep | Facility | 2022 | 19 | 19 | $3,382 | $866.13 | 25.6% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 18 | 18 | $2,952 | $739.98 | 25.1% |
| 95870 | Needle measurement of electrical activity in arm, leg, trunk or head muscles, limited study | Facility | 2022 | 17 | 34 | $2,108 | $528.51 | 25.1% |
About Dr. Rizwan Bashir, M.D
Dr. Rizwan Bashir, M.D is a Neurology healthcare provider based in Gainesville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/25/2009. The National Provider Identifier (NPI) number assigned to this provider is 1467694216.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rizwan Bashir, M.D has received a total of $2,863 in payments from pharmaceutical and medical device companies, with $862.66 received in 2024. These payments were reported across 135 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($2,863).
As a Medicare-enrolled provider, Bashir has provided services to 1,923 Medicare beneficiaries, totaling 3,385 services with total Medicare billing of $248,523. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Gainesville, GA
- Active Since 03/25/2009
- Last Updated 06/06/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1467694216
Products in Payments
- Briviact (Drug) $306.08
- NURTEC ODT (Drug) $203.14
- LINQ II (Device) $187.57
- QULIPTA (Drug) $182.88
- BRILINTA (Drug) $180.63
- EMGALITY (Drug) $138.58
- UBRELVY (Drug) $123.80
- Aimovig (Biological) $114.07
- VALTOCO (Drug) $109.88
- UPLIZNA (Drug) $105.43
- ULTOMIRIS (Biological) $88.20
- BOTOX (Biological) $83.50
- Leqembi (Drug) $74.38
- EPIDIOLEX (Drug) $73.42
- RADICAVA (Drug) $69.25
- PANZYGA (Biological) $66.99
- KESIMPTA (Drug) $60.54
- Gocovri (Drug) $52.05
- SOLIRIS (Drug) $51.95
- UPLIZNA (Biological) $47.32
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Gainesville
Dr. Steven Dekosky, Md, MD
Neurology — Payments: $143,382
Dr. Michael Okun, Md, MD
Neurology — Payments: $139,637
Dr. Daniel Cobb, Md, MD
Neurology — Payments: $83,534
James Wymer, Md, MD
Neurology — Payments: $48,627
Dr. Torge Rempe, M.d, M.D
Neurology — Payments: $38,279
Dr. Kathryn Moore, M.d, M.D
Neurology — Payments: $35,290